Visa's stock surged 9% in October, nearing record highs after China's central bank approved its domestic bankcard clearing ...
Alar Pharmaceuticals submitted an FDA Phase 2 trial application for ALA-3000, a long-acting ketamine for treatment-resistant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results